v3.26.1
Shareholders’ Equity
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Shareholders’ Equity

 

7. Shareholders’ Equity

 

Common Stock

 

The Company is authorized to issue 475,000,000 shares of common stock, par value $0.0001 per share. Each share entitles the holder to one vote on matters submitted to stockholders and to receive dividends as and if declared by the Board of Directors.

 

During the year of 2025, the Company completed the following equity issuances in connection with its initial public offering and related activities:

 

● 3,750,000 shares of common stock issued upon the closing of the IPO on August 27, 2025.
   
● 562,500 additional shares of common stock issued on September 12, 2025 upon the underwriters’ exercise of their over-allotment option.
   
● 28,312 shares of common stock issued on September 23, 2025 to satisfy a previously recorded “common stock to be issued” balance (see “Subscriptions Received – Shares to be Issued” below).

 

Following these issuances, the Company had 28,340,812 shares of its common stock issued and outstanding as of December 31, 2025, including an aggregate of 4,340,812 shares of common stock issued during the quarter ended September 30, 2025.

 

On March 18, 2026, the Company issued an aggregate of 24,000 shares of Common Stock to Dr. Huijuan Zhong as compensation for services. These shares were issued in reliance on exemption from registration requirements under Section 4(a)(2) of the Securities Act, as transactions by an issuer do not involve any public offering and are subject to contractual transfer restrictions until 12 months following the Company’s initial public offering. Following this issuance, the Company had 28,364,812 shares of common stock issued and outstanding as of June 30, 2026. For further information regarding the measurement and recognition of the related stock-based compensation, see Note 8, Stock-Based Compensation.

 

Subscriptions Received – Shares to be Issued

 

In 2019, the Company received $200,000 in cash from an existing investor for a subscription to common stock representing 0.1% of the Company’s then-anticipated total issued and outstanding shares upon completion of the IPO. This amount was recorded as “common stock to be issued” within stockholders’ equity and remained outstanding as of December 31,2024.

 

Following the successful completion of the IPO, the Company issued 28,312 shares of common stock during the quarter ended September 30, 2025 to settle this subscription in full. As of June 30, 2026, there were no remaining shares or amounts recorded as “common stock to be issued.”

 

 

Preferred Stock

 

The Company is authorized to issue 25,000,000 shares of preferred stock at $0.0001 per share. The Company’s Board of Directors also has the authority to issue additional preferred stock in one or more classes or series.

 

On June 14, 2024, the Company’s Board of Directors approved the issuance of 1,000,000 shares of Series A Super Voting Preferred Stock (“Series A Preferred Stock”) at the par value of $0.0001 per share. These shares grant the holders 40% of the total voting power of the Company’s equity voting stock. Holders of the Series A Preferred Stock do not possess any rights to dividends.

 

No shares of preferred stock were issued during the three and six months ended June 30, 2026.